| Literature DB >> 27151390 |
Steven G Morgan1, Deirdre Weymann1, Brandy Pratt2, Kate Smolina1, Emilie J Gladstone1, Colette Raymond3, Barbara Mintzes4.
Abstract
OBJECTIVES: to measure sex differences in the risk of receiving potentially inappropriate prescription drugs and to examine what are the factors that contribute to these differences.Entities:
Keywords: Beers criteria; inappropriate; older adults; older people; sex and gender; socioeconomic disparities
Mesh:
Year: 2016 PMID: 27151390 PMCID: PMC4916346 DOI: 10.1093/ageing/afw074
Source DB: PubMed Journal: Age Ageing ISSN: 0002-0729 Impact factor: 10.668
Study population characteristics, older British Columbians, 2013
| Variable | Women | Men | Women and men | ||||||
|---|---|---|---|---|---|---|---|---|---|
| % | Prevalence of PIP (%) | % | Prevalence of PIP (%) | % | Prevalence of PIP (%) | ||||
| Population | 357,165 | 100 | 31 | 303,514 | 100 | 26 | 660,679 | 100 | 28 |
| Agea | |||||||||
| 65–74 | 186,947 | 52 | 29 | 177,307 | 58 | 24 | 364,254 | 55 | 27 |
| 75–84 | 110,563 | 31 | 33 | 94,723 | 31 | 29 | 205,286 | 31 | 31 |
| 85+ | 59,655 | 17 | 30 | 31,484 | 10 | 27 | 91,139 | 14 | 29 |
| Health statusa | |||||||||
| 0 Major ADGs | 147,192 | 41 | 20 | 110,343 | 36 | 15 | 257,535 | 39 | 18 |
| 1 Major ADG | 106,297 | 30 | 33 | 91,219 | 30 | 27 | 197,516 | 30 | 30 |
| 2–3 Major ADGs | 87,272 | 24 | 41 | 84,065 | 28 | 35 | 171,337 | 26 | 38 |
| 4+ Major ADGs | 16,404 | 5 | 52 | 17,887 | 6 | 45 | 34,291 | 5 | 48 |
| Residing in long-term carea | 13,462 | 4 | 42 | 6,100 | 2 | 42 | 19,562 | 3 | 42 |
| Polypharmacy (5+ drug classes)a | 164,022 | 46 | 50 | 128,174 | 42 | 45 | 292,196 | 44 | 48 |
| Many providers (5+ physicians) | 212,080 | 59 | 39 | 180,179 | 59 | 33 | 392,259 | 59 | 36 |
| Income quintilea | |||||||||
| Lowest | 91,676 | 26 | 35 | 45,065 | 15 | 31 | 136,741 | 21 | 34 |
| Second | 70,849 | 20 | 32 | 56,699 | 19 | 28 | 127,548 | 19 | 30 |
| Third | 69,576 | 19 | 29 | 63,471 | 21 | 25 | 133,047 | 20 | 27 |
| Fourth | 68,129 | 19 | 27 | 70,154 | 23 | 24 | 138,283 | 21 | 26 |
| Fifth | 56,935 | 16 | 29 | 68,125 | 22 | 24 | 125,060 | 19 | 26 |
| Relationship statusa | |||||||||
| Single | 189,878 | 53 | 31 | 83,744 | 28 | 27 | 273,622 | 41 | 30 |
| Marriage-like relationship | 167,287 | 47 | 30 | 219,770 | 72 | 26 | 387,057 | 59 | 27 |
| Ethnicity | |||||||||
| European and other | 313,925 | 88 | 32 | 266,904 | 88 | 26 | 580,829 | 88 | 29 |
| Chinese | 31,045 | 9 | 20 | 25,784 | 8 | 21 | 56,829 | 9 | 21 |
| South Asian | 12,195 | 3 | 31 | 10,826 | 4 | 29 | 23,021 | 3 | 30 |
| Neighbourhood urbanisationa | |||||||||
| Metropolitan | 224,523 | 63 | 30 | 182,905 | 60 | 25 | 407,428 | 62 | 28 |
| Mixed urban/rural | 108,229 | 30 | 33 | 96,513 | 32 | 27 | 204,742 | 31 | 30 |
| Rural | 24,413 | 7 | 32 | 24,096 | 8 | 27 | 48,509 | 7 | 29 |
PIP, one or more potentially inappropriate prescription.
aDifferences in population characteristics statistically significant at P = 0.05.
Adjusted odds ratios for the likelihood of filling at least one potentially inappropriate prescription by community-dwelling British Columbians aged 65 and older, sex-stratified and pooled results
| Variable | Women | Men | Women + men, no interactions | Women + men, with interactions | ||||
|---|---|---|---|---|---|---|---|---|
| AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | |
| Sex | ||||||||
| Men (ref.) | – | – | 1.00 | 1.00 | ||||
| Women | – | – | 1.23 | 1.16 | ||||
| Age | ||||||||
| 65–74 (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 75–84 | 0.94 | 0.99 | 0.97–1.01 | 0.96 | 0.99 | 0.97–1.01 | ||
| 85+ | 0.89 | 0.93 | 0.91 | 0.93 | ||||
| Sex and age interaction | ||||||||
| Women × 65–74 (ref.) | – | – | – | 1.00 | ||||
| Women × 75–84 | – | – | – | 0.95 | ||||
| Women × 85+ | – | – | – | 0.95 | ||||
| Health status | ||||||||
| 0 Major ADGs (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 1 Major ADG | 1.01 | 0.99–1.03 | 1.00 | 0.97–1.02 | 1.01 | 0.99–1.02 | 1.00 | 0.97–1.02 |
| 2–3 Major ADGs | 1.07 | 1.03 | 1.00–1.06 | 1.05 | 1.03 | |||
| 4+ Major ADGs | 1.32 | 1.26 | 1.29 | 1.27 | ||||
| Sex and health status interaction | ||||||||
| Women × 0 Major ADGs (ref.) | – | – | – | 1.00 | ||||
| Women × 1 Major ADG | – | – | – | 1.01 | 0.98–1.05 | |||
| Women × 2–3 Major ADGs | – | – | – | 1.03 | 1.00–1.06 | |||
| Women × 4+ Major ADGs | – | – | – | 1.04 | 0.98–1.09 | |||
| Polypharmacy | ||||||||
| 5+ Drug classes | 4.20 | 4.14 | 4.17 | 4.18 | ||||
| Number of providers | ||||||||
| 5+ Providers | 1.14 | 1.16 | 1.15 | 1.15 | ||||
AOR, adjusted odds ratio, adjusted for all variables listed in Tables 2 and 3, combined. Values in bold are statistically significant at P = 0.05.
Adjusted odds ratios for the likelihood of filling at least one potentially inappropriate prescription by community-dwelling British Columbians aged 65 and older, sex-stratified and pooled results
| Variable | Women | Men | Women + men, no interactions | Women + men, with interactions | ||||
|---|---|---|---|---|---|---|---|---|
| AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | |
| Income quintile | ||||||||
| Lowest (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Second | 1.02 | 0.99–1.04 | 0.99 | 0.96–1.02 | 1.02 | 1.00–1.04 | 0.98 | 0.95–1.01 |
| Third | 1.00 | 0.97–1.03 | 0.94 | 0.98 | 0.96–1.00 | 0.92 | ||
| Fourth | 0.99 | 0.96–1.01 | 0.93 | 0.97 | 0.91 | |||
| Fifth | 1.02 | 0.99–1.05 | 0.88 | 0.95 | 0.86 | |||
| Sex and income interaction | ||||||||
| Women × lowest (ref.) | – | – | – | 1.00 | ||||
| Women × second | – | – | – | 1.05 | ||||
| Women × third | – | – | – | 1.10 | ||||
| Women × fourth | – | – | – | 1.11 | ||||
| Women × fifth | – | – | – | 1.22 | ||||
| Relationship status | ||||||||
| Single (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Marriage-like relationship | 1.00 | 0.98–1.02 | 0.92 | 0.97 | 0.96 | |||
| Ethnicity | ||||||||
| Other (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Chinese | 0.75 | 1.00 | 0.96–1.03 | 0.85 | 0.99 | 0.95–1.03 | ||
| South Asian | 0.83 | 0.95 | 0.91–1.00 | 0.89 | 0.95 | |||
| Sex and ethnicity interaction | ||||||||
| Women × European and other (ref.) | – | – | – | 1.00 | ||||
| Women × Chinese | – | – | – | 0.76 | ||||
| Women × South Asian | – | – | – | 0.88 | ||||
| Neighbourhood urbanisation | ||||||||
| Metropolitan (ref.) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Mixed urban/rural | 1.12 | 1.08 | 1.10 | 1.10 | ||||
| Rural | 1.13 | 1.13 | 1.13 | 1.13 | ||||
AOR, adjusted odds ratio, adjusted for all variables listed in Tables 2 and 3, combined. Values in bold are statistically significant at P = 0.05.
Prevalence and adjusted sex differences in odds of filling at least one potentially inappropriate prescription, by drug types with >1% prevalence of use, community-dwelling British Columbians aged 65 and older, 2013
| Drug class | Women | Men | Women + men | Adjusted odds ratio (women) | ||||
|---|---|---|---|---|---|---|---|---|
| % | % | % | AOR | 95% CI | ||||
| Benzodiazepines and other hypnotics (>90 days) | 38,829 | 12.9 | 21,657 | 8.4 | 60,486 | 10.8 | 1.55 | 1.52–1.58 |
| Nifedipine | 11,967 | 4.0 | 9,339 | 3.6 | 21,306 | 3.8 | 1.01 | 0.98–1.04 |
| Tertiary tricyclic antidepressants | 12,021 | 4.0 | 4,835 | 1.9 | 16,856 | 3.0 | 2.18 | 2.11–2.26 |
| Long-duration sulfonylureas | 6,664 | 2.2 | 9,015 | 3.5 | 15,679 | 2.8 | 0.56 | 0.54–0.58 |
| Estrogens with or without progestins | 14,744 | 4.9 | 33 | 0.0 | 14,777 | 2.6 | – | – |
| Non-COX selective NSAIDs (>90 days) | 7,590 | 2.5 | 5,386 | 2.1 | 12,976 | 2.3 | 1.20 | 1.15–1.24 |
| Skeletal muscle relaxants | 7,457 | 2.5 | 5,380 | 2.1 | 12,837 | 2.3 | 1.19 | 1.14–1.23 |
| Indomethacin | 2,580 | 0.9 | 8,231 | 3.2 | 10,811 | 1.9 | 0.25 | 0.24–0.27 |
| Spironolactone | 5,333 | 1.8 | 5,151 | 2.0 | 10,484 | 1.9 | 0.86 | 0.83–0.90 |
| Antiarrhythmic drugs | 3,815 | 1.3 | 4,281 | 1.7 | 8,096 | 1.4 | 0.87 | 0.83–0.91 |
| Fast-acting insulin | 3,228 | 1.1 | 4,434 | 1.7 | 7,662 | 1.4 | 0.64 | 0.61–0.67 |
| First-generation antihistamines | 4,261 | 1.4 | 3,173 | 1.2 | 7,434 | 1.3 | 1.10 | 1.04–1.15 |
| Anti-infective | 5,649 | 1.9 | 1,323 | 0.5 | 6,972 | 1.2 | 3.87 | 3.63–4.12 |
| Alpha 1 blockers | 898 | 0.3 | 4,965 | 1.9 | 5,863 | 1.0 | – | – |
| Androgens | 164 | 0.1 | 4,252 | 1.6 | 4,416 | 0.8 | – | – |
AOR, adjusted odds ratio, adjusted for age, health status, polypharmacy, receipt of prescriptions from multiple doctors, income, marital status, ethnicity and neighbourhood urbanisation.